Pediatrix Medical Group, Inc.
DE ˙ DB ˙ US58502B1061
19,10 € ↑0,40 (2,14%)
2026-06-05
DEL PRIS
SecurityDE:PDC / Pediatrix Medical Group, Inc.
InstitutionJpmorgan Chase & Co
Latest Disclosed Ownership232,955 shares
Latest Disclosed Value $ 4,845,464
Jpmorgan Chase & Co ownership in PDC / Pediatrix Medical Group, Inc.

On May 13, 2026 - Jpmorgan Chase & Co filed a 13F-HR/A form disclosing ownership of 232,955 shares of Pediatrix Medical Group, Inc. (DE:PDC) valued at $4,193,190 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 710,717 shares of Pediatrix Medical Group, Inc.. This represents a change in shares of -67.22% during the quarter. The current value of the position is $4,449,440 USD.

Jpmorgan Chase & Co has a history of taking positions in derivatives of the underlying security (PDC) in the form of stock options.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

DE:PDC / Pediatrix Medical Group, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F/A-1 PEDIATRIX MEDICAL GROUP COMMON 58502B106 232,955 -477,762 -67.22 4,845 -68.13 0.0000
2026-05-13 2026-03-31 13F PEDIATRIX MEDICAL GROUP COMMON 58502B106 0 -100.00 0
2026-02-11 2025-12-31 13F PEDIATRIX MEDICAL GROUP COMMON 58502B106 710,717 -116,358 -14.07 15,202 9.74 0.0010
2025-11-26 2025-09-30 13F/A-1 PEDIATRIX MEDICAL GROUP COMMON 58502B106 827,075 140,577 20.48 13,854 40.63 0.0008
2025-11-07 2025-09-30 13F PEDIATRIX MEDICAL GROUP COMMON 58502B106 827,075 140,577 13,854 0.0001
2025-08-12 2025-06-30 13F PEDIATRIX MEDICAL GROUP COMMON 58502B106 686,498 -246,610 -26.43 9,851 -27.14 0.0006
2025-05-12 2025-03-31 13F PEDIATRIX MEDICAL GROUP COMMON 58502B106 933,108 1,508 0.16 13,521 10.62 0.0010
2025-02-12 2024-12-31 13F PEDIATRIX MEDICAL GROUP COMMON 58502B106 931,600 -10,712 -1.14 12,223 11.91 0.0009
2024-12-26 2024-09-30 13F/A-1 PEDIATRIX MEDICAL GROUP COMMON 58502B106 942,312 -59,509 -5.94 10,921 44.40 0.0008
2024-11-08 2024-09-30 13F PEDIATRIX MEDICAL GROUP COMMON 58502B106 942,312 -59,509 10,921 0.0008
2024-12-26 2024-06-30 13F/A-1 PEDIATRIX MEDICAL GROUP COMMON 58502B106 1,001,821 -68,238 -6.38 7,564 -29.53 0.0006
2024-08-12 2024-06-30 13F PEDIATRIX MEDICAL GROUP COMMON 58502B106 1,001,821 -68,238 7,564 0.0006
2024-12-26 2024-03-31 13F/A-1 PEDIATRIX MEDICAL GROUP COMMON 58502B106 1,070,059 935,774 696.86 10,733 759.94 0.0009
2024-05-10 2024-03-31 13F PEDIATRIX MEDICAL GROUP COMMON 58502B106 1,070,059 935,774 10,733 0.0009
2024-12-26 2023-12-31 13F/A-1 PEDIATRIX MEDICAL GROUP COMMON 58502B106 134,285 8,819 7.03 1,249 -21.71 0.0001
2024-02-12 2023-12-31 13F PEDIATRIX MEDICAL GROUP COMMON 58502B106 134,285 8,819 1,249 0.0001
2023-11-14 2023-09-30 13F PEDIATRIX MEDICAL GROUP COMMON 58502B106 125,466 -18,669 -12.95 1,595 -22.17 0.0002
2023-08-11 2023-06-30 13F PEDIATRIX MEDICAL GROUP COMMON 58502B106 144,135 19,604 15.74 2,048 10.29 0.0002
2023-05-18 2023-03-31 13F/A-1 PEDIATRIX MEDICAL GROUP COMMON 58502B106 124,531 20,166 19.32 1,857 185,600.00 0.0002
2023-05-11 2023-03-31 13F PEDIATRIX MEDICAL GROUP COMMON 58502B106 21,741 -82,624 922 0.0000
2023-02-13 2022-12-31 13F PEDIATRIX MEDICAL GROUP COMMON 58502B106 104,365 6,819 6.99 2 -99.94 0.0002
2022-11-14 2022-09-30 13F PEDIATRIX MEDICAL GROUP COMMON 58502B106 97,546 -148,845 -60.41 1,611 -68.88 0.0002
2022-08-11 2022-06-30 13F MEDNAX COMMON 58502B106 246,391 54,322 28.28 5,177 14.79 0.0007
2022-05-11 2022-03-31 13F MEDNAX COMMON 58502B106 192,069 -60,890 -24.07 4,510 -34.48 0.0005
2022-02-11 2021-12-31 13F/A-1 MEDNAX COMMON 58502B106 252,959 26,791 11.85 6,883 7.05 0.0008
2022-02-10 2021-12-31 13F MEDNAX COMMON 58502B106 252,959 26,791 6,883 0.0001
2021-11-12 2021-09-30 13F MEDNAX COMMON 58502B106 226,168 -30,343 -11.83 6,430 -16.86 0.0008
2021-08-12 2021-06-30 13F MEDNAX COMMON 58502B106 256,511 -144,706 -36.07 7,734 -24.31 0.0009
2021-05-12 2021-03-31 13F MEDNAX COMMON 58502B106 401,217 107,139 36.43 10,218 41.58 0.0014
2021-02-19 2020-12-31 13F/A-1 MEDNAX COMMON 58502B106 294,078 -622,583 -67.92 7,217 -50.95 0.0011
2021-02-11 2020-12-31 13F MEDNAX COMMON 58502B106 294,078 -622,583 7,217 178.4816
2020-11-12 2020-09-30 13F/A-1 MEDNAX COMMON 58502B106 916,661 63,366 7.43 14,713 0.83 0.0025
2020-11-12 2020-09-30 13F MEDNAX COMMON 58502B106 916,661 14,713
2020-08-11 2020-06-30 13F MEDNAX COMMON 58502B106 853,295 681,882 397.80 14,592 631.06 0.0028
2020-05-12 2020-03-31 13F MEDNAX COMMON 58502B106 171,413 27,492 19.10 1,996 -50.11 0.0005
2020-02-11 2019-12-31 13F MEDNAX COMMON 58502B106 143,921 -88,217 -38.00 4,001 -23.82 0.0007
2019-11-12 2019-09-30 13F MEDNAX COMMON 58502B106 232,138 -29,964 -11.43 5,252 -18.55 0.0010
2019-08-07 2019-06-30 13F MEDNAX COMMON 58502B106 262,102 -19,374 -6.88 6,448 -15.68 0.0013
2019-05-07 2019-03-31 13F MEDNAX COMMON 58502B106 281,476 106,840 61.18 7,647 32.69 0.0016
2019-02-11 2018-12-31 13F MEDNAX COMMON 58502B106 174,636 -119,413 -40.61 5,763 -58.00 0.0013
2018-11-13 2018-09-30 13F/A-1 MEDNAX COMMON 58502B106 294,049 -219,119 -42.70 13,721 -38.22 0.0026
2018-11-07 2018-09-30 13F MEDNAX COMMON 58502B106 294,049 -219,119 13,721
2018-08-14 2018-06-30 13F MEDNAX COMMON 58502B106 513,168 -132,694 -20.55 22,209 -38.19 0.0046
2018-05-10 2018-03-31 13F MEDNAX COMMON 58502B106 645,862 92,070 16.63 35,929 21.41 0.0077
2018-02-13 2017-12-31 13F MEDNAX COMMON 58502B106 553,792 -202,423 -26.77 29,594 -9.24 0.0062
2017-11-09 2017-09-30 13F MEDNAX COMMON 58502B106 756,215 686,678 987.50 32,607 676.54 0.0072
2017-08-09 2017-06-30 13F MEDNAX COMMON 58502B106 69,537 -10,073 -12.65 4,199 -23.99 0.0010
2017-05-10 2017-03-31 13F MEDNAX COMMON 58502B106 79,610 -7,699 -8.82 5,524 -5.09 0.0013
2017-02-06 2016-12-31 13F MEDNAX COMMON 58502B106 87,309 -11,310 -11.47 5,820 -10.93 0.0014
2016-11-04 2016-09-30 13F MEDNAX COMMON 58502B106 98,619 -408 -0.41 6,534 -8.90 0.0016
2016-08-08 2016-06-30 13F MEDNAX COMMON 58502B106 99,027 -145 -0.15 7,172 11.92 0.0018
2016-05-10 2016-03-31 13F MEDNAX COMMON 58502B106 99,172 -3,752 -3.65 6,408 -13.12 0.0016
2016-02-12 2015-12-31 13F MEDNAX COMMON 58502B106 102,924 50,841 97.62 7,376 84.40 0.0019
2015-11-13 2015-09-30 13F MEDNAX COMMON 58502B106 52,083 -130,502 -71.47 4,000 -70.44 0.0011
2015-08-14 2015-06-30 13F MEDNAX COMMON 58502B106 182,585 54,544 42.60 13,531 45.73 0.0032
2015-05-15 2015-03-31 13F MEDNAX COMMON 58502B106 128,041 -10,422 -7.53 9,285 1.43 0.0021
2015-02-13 2014-12-31 13F MEDNAX COMMON 58502B106 138,463 -285,467 -67.34 9,154 -60.61 0.0021
2014-12-08 2014-09-30 13F/A-1 MEDNAX COMMON 58502B106 423,930 99,113 30.51 23,240 23.04 0.0055
2014-11-14 2014-09-30 13F MEDNAX COMMON 58502B106 423,930 23,240
2014-09-03 2014-06-30 13F/A-1 MEDNAX COMMON 58502B106 324,817 162,143 99.67 18,888 87.33 0.0048
2014-08-14 2014-06-30 13F MEDNAX COMMON 58502B106 324,817 18,888
2014-05-15 2014-03-31 13F MEDNAX COMMON 58502B106 162,674 29,406 22.07 10,083 41.77 0.0028
2014-02-26 2013-12-31 13F/A-1 MEDNAX COMMON 58502B106 133,268 90,652 212.72 7,112 66.25 0.0020
2014-02-13 2013-12-31 13F MEDNAX COMMON 58502B106 133,268 7,112
2013-10-31 2013-09-30 13F MEDNAX COMMON 58502B106 42,616 5,777 15.68 4,278 26.76 0.0013
2013-08-13 2013-06-30 13F MEDNAX COMMON 58502B106 36,839 36,839 3,375 0.0011
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2017-05-10 2017-03-31 13F MEDNAX OPTION Put 0 -100.00 0 -100.00 n/a n/a n/a
2017-02-06 2016-12-31 13F MEDNAX OPTION Put 36,000 0.00 2,400 0.63 n/a n/a n/a
2016-11-04 2016-09-30 13F MEDNAX OPTION Put 36,000 2,385 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.